Published: Apr 2016
ACE Report #8935
Ace Report Cover Metabolic Disorders

WCO-IOF 2016: Odanacatib has a significant effect on volumetric BMD versus placebo

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Effect of odanacatib on bone mineral density and estimated bone strength in postmenopausal women: a CT-based substudy of the phase 3 long-term odanacatib fracture trial (LOFT)

Contributing Authors: H Genant A Lombardi K Engelke TM Keaveny B Langdahl T DeVilliers S Ather H Giezek A Leung A de Papp

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.